Kollins Scott H
ADHD Program, Department of Psychiatry and Behavioral Science, Duke University School of Medicine, Durham, North Carolina 27705, USA.
Am J Addict. 2007;16 Suppl 1:35-42; quiz 43-4. doi: 10.1080/10550490601082775.
The use of psychostimulants to treat attention-deficit/hyperactivity disorder (ADHD) has been controversial for a number of reasons. In an effort to clarify the extent to which the psychostimulant methylphenidate has abuse potential, the existing published evidence has been reviewed and is summarized here, with an emphasis on delineating a number of related but independent issues that are often confused. The existing evidence reviewed is pertinent to three questions: Does stimulant drug use increase the risk for substance abuse later in life? Do ADHD medications have the potential for abuse?, and What is the distinction between drug abuse and misuse/diversion with respect to ADHD medication?
使用精神振奋剂治疗注意力缺陷多动障碍（ADHD）一直存在诸多争议。为了阐明精神振奋剂哌醋甲酯具有滥用潜力的程度，我们对现有的已发表证据进行了回顾并在此进行总结，重点是厘清一些经常被混淆的相关但独立的问题。所回顾的现有证据与三个问题相关：使用兴奋剂药物会增加日后出现药物滥用的风险吗？ADHD药物有被滥用的可能性吗？以及就ADHD药物而言，药物滥用与药物误用/药物转移之间的区别是什么？
